208 related articles for article (PubMed ID: 679196)
21. Chemotherapy of advanced L1210 leukemia with platinum compounds in combination with other antitumor agents.
Gale GR; Atkins LM; Meischen SJ; Smith AB; Walker EM
Cancer Treat Rep; 1977; 61(3):445-50. PubMed ID: 872142
[TBL] [Abstract][Full Text] [Related]
22. MX2, a morpholino anthracycline, as a new antitumor agent against drug-sensitive and multidrug-resistant human and murine tumor cells.
Watanabe M; Komeshima N; Nakajima S; Tsuruo T
Cancer Res; 1988 Dec; 48(23):6653-7. PubMed ID: 3180075
[TBL] [Abstract][Full Text] [Related]
23. Effects of cimetidine combination with cyclophosphamide in transplanted murine tumors.
Khandalekar DD; Ganu UK; Gokhale SV
Indian J Physiol Pharmacol; 1989; 33(3):171-4. PubMed ID: 2592043
[TBL] [Abstract][Full Text] [Related]
24. Combined therapy of L1210 leukemia with cyclophosphamide and lycurim.
Stoychkov JN; Milushev AS; Todorov DK
Neoplasma; 1980; 27(1):33-6. PubMed ID: 6892839
[TBL] [Abstract][Full Text] [Related]
25. Studies with 2,5-piperazinedione, 3,6-bis(5-chloro-2-piperidyl)-,dihydrochloride. III. Biochemical and therapeutic effects in L1210 leukemias sensitive and resistant to alkylating agents: comparison with melphalan, cyclophosphamide, and BCNU.
Schabel FM; Trader MW; Laster WR; Shaddix SC; Brockman RW
Cancer Treat Rep; 1976 Sep; 60(9):1325-33. PubMed ID: 1016968
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of antileukemic agents in advanced leukemia L1210 in mice. X.
Kline I; Gang M; Tyrer DD; Venditti JM; Artis EW; Goldin A
Cancer Chemother Rep 2; 1972 Nov; 3(1):1-69. PubMed ID: 4660732
[No Abstract] [Full Text] [Related]
27. Antileukemic synergism between cyclophosphamide and an antitumor platinum compound.
Walker EM; Gale GR
Res Commun Chem Pathol Pharmacol; 1973 Sep; 6(2):419-25. PubMed ID: 4750093
[No Abstract] [Full Text] [Related]
28. Optimum time sequence for the administration of vincristine and cyclophosphamide in vivo.
Razek A; Vietti T; Valeriote F
Cancer Res; 1974 Aug; 34(8):1857-61. PubMed ID: 4842737
[No Abstract] [Full Text] [Related]
29. [Therapeutic effectiveness of carminomycin (CRM) in combination with dibromodulcitol (DBD) compared with the combination vincristine, cyclophosphamide, methotrexate, 5-fluorouracil (VCMF) on some tumor systems (author's transl)].
Nowak C; Arnold W; Henneberger G; Tanneberger S
Arch Geschwulstforsch; 1980; 50(8):747-57. PubMed ID: 7224818
[TBL] [Abstract][Full Text] [Related]
30. Circadian bioperiodic response of mice bearing advanced L1210 leukemia to combination therapy with adriamycin and cyclophosphamide.
Scheving LE; Burns ER; Pauly JE; Halberg F
Cancer Res; 1980 May; 40(5):1511-5. PubMed ID: 7370988
[No Abstract] [Full Text] [Related]
31. Biochemical and pharmacologic study of therapeutic synergism with cyclophosphamide plus methotrexate in murine L1210 leukemia.
Klubes P; Cerna I
Cancer Treat Rep; 1981; 65(1-2):107-14. PubMed ID: 7226161
[TBL] [Abstract][Full Text] [Related]
32. Synergistic action of 2-chlorodeoxyadenosine and cyclophosphamide on murine leukemias L1210 and P388.
Góra-Tybor J; Robak T
Acta Haematol Pol; 1993; 24(2):177-82. PubMed ID: 8103959
[TBL] [Abstract][Full Text] [Related]
33. A review of carminomycin-a new anthracycline developed in the USSR.
Crooke ST
J Med; 1977; 8(5):295-316. PubMed ID: 338849
[No Abstract] [Full Text] [Related]
34. [Use of carminomycin in bladder cancer].
Zak BI; Korol'chuk VP; Abrazheev VG; Vakulina TI; Skriabnev GA
Vopr Onkol; 1979; 25(2):63-4. PubMed ID: 371127
[No Abstract] [Full Text] [Related]
35. [Preliminary results of a cooperative clinical study of the new antitumor antibiotic, carminomycin].
Borisov VI; Lipatov AM; Perevodchikova NI; Alekseev NA; Vygovskaia IaI
Antibiotiki; 1976 Nov; 21(11):1026-30. PubMed ID: 798543
[TBL] [Abstract][Full Text] [Related]
36. [Joint therapy of experimental tumors with diazan in combination with antibiotics].
Volkova LM; D'iachkovskaia RF; Konovalova NP
Antibiotiki; 1979 Apr; 24(4):300-3. PubMed ID: 87148
[TBL] [Abstract][Full Text] [Related]
37. Antileukemic effects of recombinant human tumor necrosis factor alpha (rh-TNF alpha) with cyclophosphamide or methotrexate on leukemia L1210 and leukemia P388 in mice.
Warzocha K; Robak T
Acta Haematol Pol; 1992; 23(1):55-62. PubMed ID: 1615753
[TBL] [Abstract][Full Text] [Related]
38. [Case of the successful use of carminomycin in combination with cyclophosphane and vincristine in treating ectopic chondrosarcoma of rare localization in a 5-month-old infant].
Gusev LI; Iasonov AV; Poliakov VG
Antibiotiki; 1978 Jul; 23(7):637-8. PubMed ID: 677854
[TBL] [Abstract][Full Text] [Related]
39. Predictive values of the in vivo diffusion chamber for cyclophosphamide treatment of L1210 murine leukemia.
Anderson KC; Humphrey RL; Sensenbrenner LL
Cancer Res; 1983 May; 43(5):2030-3. PubMed ID: 6831434
[TBL] [Abstract][Full Text] [Related]
40. Molecular pharmacological differences between carminomycin and its analog, carminomycin-11-methyl ether, and adriamycin.
DuVernay VH; Pachter JA; Crooke ST
Cancer Res; 1980 Feb; 40(2):387-94. PubMed ID: 7356521
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
